Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 20;12(12):2907.
doi: 10.3390/biomedicines12122907.

The Effects of Beta-Blockers on Leukocytes and the Leukocyte Subpopulation in Heart Failure Patients

Anca Daniela Farcaş  1   2 , Mirela Anca Stoia  1   2 , Diana Larisa Mocan-Hognogi  1   2 , Cerasela Mihaela Goidescu  1   3 , Alexandra Florina Cocoi  4 , Florin Petru Anton  1   2
Affiliations

The Effects of Beta-Blockers on Leukocytes and the Leukocyte Subpopulation in Heart Failure Patients

Anca Daniela Farcaş et al. Biomedicines. .

Abstract

Background/Objectives: Some specific types of white blood cells (WBCs) and the neutrophil/lymphocyte ratio (NLR) are independent predictors of outcome for heart failure (HF) patients. WBC redistribution is induced by catecholamines, and therefore we evaluate how different types of beta-blockers (BBs) influence it. Methods: The HF patients were clinically evaluated, and blood was drawn to measure N-Terminal pro-B-type natriuretic peptide (NT-proBNP), WBC-differential formula, etc. Results: On admission, 61.16% of patients who used a BB had no significant difference in the number of lymphocytes (Lym) and neutrophils (Neu), but NLR and NT- proBNP were significantly lower compared with those without BB. NT-proBNP correlated with BB dose on admission and was significantly lower in patients treated with Metoprolol (Met) as compared with Carvedilol (Car). The type and dose of BB used was responsible for 6.1% and 5.9% of the variability in the number of Lym and Neu, respectively. Patients treated with ≥100 mg Met/day had a higher Lym number, but not of Neu, with reduced NLR, compared with lower doses. Patients treated with ≥25 mg Car/day had a lower Lym number and a greater Neu number, compared with lower doses, with increased NLR. Conclusions: However, both BBs had the same rehospitalization rate during the 12 month follow-up and had an improved outcome.

Keywords: beta-blockers; cardiovascular drug; heart failure; leukocyte subpopulation; neutrophil–lymphocyte ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Design of the study.
Figure 2
Figure 2
The correlations between the levels of NT pro-BNP with metoprolol (higher doses reduce the level of NT proBNP more).
Figure 3
Figure 3
The correlations between the levels of NT pro-BNP with carvedilol (higher doses reduce the level of NT proBNP more).
Figure 4
Figure 4
Adrenergic governance of neutrophil functions in physiology and pathology. Use of β-blockers restores neutrophil functions in diseased states [33].
Figure 5
Figure 5
Adrenergic signaling in cardiomyocytes and vasculature during adulthood (A,C) and aging (B,D) [34].
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Becher P.M., Lund L.H., Coats A.J., Savarese G. An update on global epidemiology in heart failure. Eur. Heart J. 2022;43:3005–3007. doi: 10.1093/eurheartj/ehac248. - DOI - PubMed
    1. Farcas A.D., Stoia M.A., Anton F.P., Hognogi D.M., Ianos R.D., Hojda S.E.S., Gavrila I.L., Lutac D., Burian I.I., Simiti L.A.V. The Lymphocyte Count and Neutrophil/lymphocyte Ratio are Independent Predictors for Adverse Cardiac Events in Ischemic Heart Failure but not with Non-ischemic Heart Failure. Rev. Chim. 2016;76:2091–2094.
    1. Goidescu C., Farcas A., Anton F., Vida-Simiti L. The Pattern of Ventricular Remodeling Influences the Level of Oxidative Stress in Heart Failure Patients. Rev. Chim. 2017;68:1506–1511. doi: 10.37358/RC.17.7.5705. - DOI
    1. Harding D., Chong M.H.A., Lahoti N., Bigogno C.M., Prema R., Mohiddin S.A., Marelli-Berg F. Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy. J. Intern. Med. 2023;293:23–47. doi: 10.1111/joim.13556. - DOI - PubMed
    1. Curran F.M., Bhalraam U., Mohan M., Singh J.S., Anker S.D., Dickstein K., Doney A.S., Filippatos G., George J., Metra M., et al. Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 2021;8:3168–3179. doi: 10.1002/ehf2.13424. - DOI - PMC - PubMed

LinkOut - more resources